Target Name: Inward Rectifier Potassium Channel
NCBI ID: P42103
Review Report on Inward Rectifier Potassium Channel Target / Biomarker Content of Review Report on Inward Rectifier Potassium Channel Target / Biomarker
Inward Rectifier Potassium Channel
Other Name(s): Inward Rectifier Potassium Channel

Inward Rectifier Potassium Channels: Functions and Interactions

Inward rectifier potassium channels (IRCs) are a type of ion channel that plays a crucial role in the regulation of intracellular potassium levels. These channels are also known as inactivated potassium channels (IKs) because they are inactive until they are activated by an external electrical potential. IRCs are found in various tissues and cells throughout the body and are involved in a wide range of physiological processes, including muscle contractions, nerve impulses, and brain function.

Overview of Inward Rectifier Potassium Channels

IRCs are a subtype of ion channel that is characterized by its ability to rectify potassium ions in the intracellular space. These channels are responsible for maintaining the resting membrane potential of the cell and play a key role in the regulation of ion traffic and signaling.

IRCs are composed of a proteinaceous cytoplasmic domain and a hyperpolarized transmembrane region. The cytoplasmic domain contains a unique ion-selective mechanism that allows IRCs to selectively regulate the movement of potassium ions. The transmembrane region is composed of multiple voltage-dependent ion channels that are responsible for the regulation of the ion current.

Functions and Interactions

IRCs are involved in the regulation of a wide range of physiological processes in the body, including muscles, nerve contractions, and brain function. They are also involved in the regulation of ion transport, including the movement of calcium and magnesium ions.

IRCs play a key role in the regulation of muscle contractions. When muscle cells are activated, IRCs allow the rapid recruitment of calcium ions, which results in muscle contractions. Additionally, IRCs are also involved in the regulation of muscle relaxation and the regulation of muscle tone.

IRCs are also involved in the regulation of nerve impulses. When nerve impulses are transmitted to muscle cells, IRCs allow the rapid recruitment of potassium ions, which results in muscle contractions. Additionally, IRCs are also involved in the regulation of the myasthenia gravis, a condition characterized by muscle weakness and fatigue.

IRCs are also involved in the regulation of brain function. They play a key role in the regulation of neuronal excitability and are involved in the development and maintenance of neural circuits.

Drugs that Target Inward Rectifier Potassium Channels

The use of drugs that target Inward Rectifier Potassium Channels (IRCs) has become an important area of 鈥嬧?媟esearch in recent years. These drugs are often used to treat various neurological and psychiatric disorders, including epilepsy, migraine, and heart disease.

One of the most well-known drugs that targets IRCs is used to treat epilepsy. epilepsy is a condition characterized by the rapid and frequent occurrence of epileptic episodes. The drug used to treat epilepsy is called a partial anti-epileptic drug (SSRI), which is a type of antidepressant drug that targets the regulation of ion channels, including IRCs.

Another drug that targets IRCs is used to treat migraine. Migraine is a condition characterized by the development of severe headaches, often accompanied by nausea and vomiting. The drug used to treat migraines is called a serotonin antagonist, which is a type of antidepressant drug that targets the regulation of ion channels, including IRCs.

Another drug that targets IRCs is used to treat heart disease. Heart disease is a condition characterized by the development of thickened heart muscle, which can lead to the inability to pump blood throughout the body. The drug used to treat heart disease is called a beta -blocker, which is a type of drug that targets the regulation of ion channels, including IRCs.

Conclusion

In conclusion, Inward rectifier potassium channels (IRCs) are a type of ion channel that is characterized by its ability to rectify potassium ions in the intracellular space. These channels are involved in a wide range of physiological processes in the body and play a key role in the regulation of ion traffic and signaling. The use of drugs that target IRCs, such as SSRIs, serotonin antagonists, and beta-blockers, has become an important area of 鈥嬧?媟esearch in recent years. Further research is needed to fully understand the role of IRCs in various physiological processes

Protein Name: Inward Rectifier Potassium Channel (nonspecified Subtype)

The "Inward Rectifier Potassium Channel Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Inward Rectifier Potassium Channel comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IP6K1 | IP6K2 | IP6K3 | IPCEF1 | IPMK | IPO11 | IPO11-LRRC70 | IPO13 | IPO4 | IPO5 | IPO7 | IPO8 | IPO9 | IPO9-AS1 | IPP | IPPK | IPW | IQCA1 | IQCA1L | IQCB1 | IQCC | IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK | IQCM | IQCN | IQGAP1 | IQGAP2 | IQGAP3 | IQSEC1 | IQSEC2 | IQSEC3 | IQSEC3P3 | IQUB | IRAG1 | IRAG1-AS1 | IRAG2 | IRAK1 | IRAK1BP1 | IRAK2 | IRAK3 | IRAK4 | IREB2 | IRF1 | IRF1-AS1 | IRF2 | IRF2BP1 | IRF2BP2 | IRF2BPL | IRF3 | IRF4 | IRF5 | IRF6 | IRF7 | IRF8 | IRF9 | IRGC | IRGM | IRGQ | IRS1 | IRS2 | IRS4 | IRX1 | IRX2 | IRX2-DT | IRX3 | IRX4 | IRX5 | IRX6 | ISCA1 | ISCA1P1 | ISCA2 | ISCU | ISG15 | ISG20 | ISG20L2 | ISL1 | ISL1-DT | ISL2 | ISLR | ISLR2 | ISM1 | ISM2 | ISOC1 | ISOC2 | Isocitrate dehydrogenase 3 (NAD+) | Isocitrate dehydrogenases | Isoleucyl-tRNA synthetase | IST1 | ISWI Chromatin Remodeling Complex